SCHEMBL4767712

SCHEMBL4767712

CCn1c(=O)c([N+](=O)[O-])c(C=Cc2cnn(Cc3ccccc3F)c2)n(CCCOC)c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 7/20 0.39
ADORA2A P29274 6/20 0.39
ADORA1 P30542 2/20 0.39
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
MAPT P10636 5/20 0.36
GAA P10253 1/20 0.36
TP53 P04637 1/20 0.35
POLB P06746 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 3/20 0.34
PKM P14618 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPK1 P28482 1/20 0.34
PKLR P30613 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763211 0.92 ADORA2B (0.42) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4771427 0.91 ADORA2B (0.41) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4766145 0.91 ADORA2B (0.41) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4763491 0.90 ADORA2B (0.42) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4763488 0.90 ADORA2B (0.42) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4767707 0.90 ADORA2B (0.46) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4763889 0.89 ADORA2B (0.46) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4763896 0.89 ADORA2B (0.46) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4769328 0.87 ADORA2B (0.49) ADORA2BADORA2AADORA1NCOA1NCOA3
SCHEMBL4769321 0.87 ADORA2B (0.49) ADORA2BADORA2AADORA1NCOA1NCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed